Exploring the Landscape of Injury and Repair in the Human Oesophagus
NCT06820151 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-02-11
Summary
The goal of this study limited to working with human tissue samples is to delineate the mechanisms defining appropriate oesophageal injury and repair and to use this information to understand how these rules are dysregulated and result in cancer formation in adult patients undergoing endoluminal vacuum therapy (EVT therapy) for the treatment of perforations to the oesophagus.
The main question\[s\] it aims to answer are:
* to gain a deeper understanding of the processes underlying tissue regeneration and repair in the oesophagus and upper gastro-intestinal tract following physical injury
* to identify the similarities in the processes of regeneration and early carcinogenesis
Participants will take part in the study during their usual EVT therapy schedule. Tissue brushings and pinch biopsies will also be taken.
Conditions
- Perforations to the Oesophagus
Interventions
- OTHER
-
Sample collection
Sample collection: EVT sponges, tissue brushings and pinch biopsies
Sponsors & Collaborators
-
The Wellcome Sanger Institute
lead OTHER
Principal Investigators
-
AYESHA NOORANI, PhD MRCS · Genome Research Limited operating as The Wellcome Sanger Institute
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2026-04-29
- Completion
- 2026-04-29
Countries
- United Kingdom
Study Locations
More Related Trials
-
Endoscopic Therapy of Early Cancer in Barretts Esophagus
NCT00217087 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Ablation Therapy on Barrett's Esophagus
NCT00587314 ·Status: ENROLLING_BY_INVITATION
-
Molecular Analysis of Gastric and OEsophageal Cancers STudy
NCT06702384 ·Status: WITHDRAWN
-
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
NCT02938195 ·Status: UNKNOWN ·Phase: PHASE2
-
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
NCT06381583 ·Status: COMPLETED
-
Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer
NCT02253602 ·Status: COMPLETED ·Phase: NA
-
Proton Beam Therapy in the Treatment of Esophageal Cancer
NCT03482791 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
NCT04001478 ·Status: UNKNOWN
-
Esophageal cAncer Screening Trial
NCT04609813 ·Status: COMPLETED
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
NCT03223662 ·Status: TERMINATED ·Phase: PHASE2
-
Fluorescence Endoscopy of Esophageal Carcinoma
NCT03558724 ·Status: TERMINATED ·Phase: PHASE1
-
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers
NCT05688176 ·Status: RECRUITING
-
Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?
NCT00583934 ·Status: COMPLETED
-
Diagnostic Value of Optical Enhancement Technology in Early Esophageal Squamous Neoplasia
NCT02851264 ·Status: UNKNOWN
-
Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell Carcinoma
NCT03404921 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Esophageal Squamous Cancer With the Capsule Sponge Device
NCT06418516 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Organoid Based Response Prediction in Esophageal Cancer
NCT03283527 ·Status: UNKNOWN
-
A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal Cancer
NCT05208775 ·Status: UNKNOWN ·Phase: NA
-
Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma
NCT00215462 ·Status: COMPLETED ·Phase: PHASE2
-
Esophageal Stump Washout
NCT01980394 ·Status: COMPLETED ·Phase: NA
-
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT02358863 ·Status: TERMINATED ·Phase: NA
-
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
NCT05745857 ·Status: RECRUITING ·Phase: PHASE2
-
Esophageal Cancer Tissue Banking
NCT01780961 ·Status: COMPLETED
-
WavSTAT® Optical Biopsy System to Target Esophageal Biopsies
NCT00747136 ·Status: TERMINATED